ESC 365 - The PCSK9 targeted therapy - the best strategy to prevent cardiovascular complications in very high-risk patients in poland. Real-life data from the national health found B101 reimbursement program

Open Access

The PCSK9 targeted therapy - the best strategy to prevent cardiovascular complications in very high-risk patients in poland. Real-life data from the national health found B101 reimbursement program

Session: ePosters in pharmacology and pharmacotherapy

Topic: Cardiovascular Pharmacotherapy

Speaker: Professor M. Banach (Lodz, PL)

Event: Heart Failure 2025

Congress Presentation

Add to my library

About the speaker

Professor Maciej Banach

Medical University of Lodz, Lodz (Poland)

8 presentations

2 followers

5 more presentations in this session

Individual natriuretic and diuretic response in acute heart failure: insights from the PUSH-AHF pharmacological substudy

Speaker: Doctor I. Beldhuis (Groningen, NL)

Real-world SGLT2i prescribing in an elderly population; a tertiary centre review

Speaker: Doctor G. O Dea (Limerick, IE)

Association between congestion and aspirin resistance in patients with chronic coronary syndrome

Speaker: Doctor I. Meray (Tyre, LB)

Supernormal cardiac function: exercise vs. dapagliflozin

Speaker: Miss R. Vago (Debrecen, HU)

Prevalence and influence on renal function of diuretic treatment in patients with heart failure

Speaker: Doctor L. Alcoberro (Hospitalet De Llobregat, ES)

Access the full session

ePosters in pharmacology and pharmacotherapy

Speakers: Professor M. Banach, Doctor I. Beldhuis, Doctor G. O Dea, Doctor I. Meray, Miss R. Vago...

About the event

Heart Failure 2025

17 May - 20 May 2025

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources

Explore sponsored resources

Explore sponsored resources